{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:16:22Z","timestamp":1790424982516,"version":"4.1.0"},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7375","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T07:43:06Z","timestamp":1552462986000},"source":"Crossref","is-referenced-by-count":1,"title":["Induction of APOBEC3B cytidine deaminase in HTLV\u20111\u2011infected humanized mice"],"prefix":"10.3892","author":[{"given":"Jinchun","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Microbiology, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Takenouchi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung\u2011Il","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Science, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun\u2011Ichi","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Kansai Medical University, Hirakata, Osaka 573\u20111010, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"key20200713120710_b1-etm-0-0-7375","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: Clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"key20200713120710_b2-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-1 associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"key20200713120710_b3-etm-0-0-7375","first-page":"472","article-title":"Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I","volume":"33","author":"Nakao","year":"1989","journal-title":"Jpn J Ophthalmol"},{"key":"key20200713120710_b4-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1126\/science.6316502","article-title":"Productive infection and cell free transmission of human T-cell leukemia virus in a non-lymphoid cell line","volume":"222","author":"Clapham","year":"1983","journal-title":"Science"},{"key":"key20200713120710_b5-etm-0-0-7375","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/JVI.69.3.1907-1912.1995","article-title":"Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells","volume":"69","author":"Derse","year":"1995","journal-title":"J Virol"},{"key":"key20200713120710_b6-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev.me.30.020179.001031","article-title":"Clonal original of human tumors","volume":"30","author":"Fialkow","year":"1979","journal-title":"Annu Rev Med"},{"key":"key20200713120710_b7-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1098\/rstb.2008.0185","article-title":"APOBEC proteins and intrinsic resistance to HIV-1 infection","volume":"364","author":"Malim","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key20200713120710_b8-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat Genet"},{"key":"key20200713120710_b9-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"45","author":"Burns","year":"2013","journal-title":"Nat Genet"},{"key":"key20200713120710_b10-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"e1000928","DOI":"10.1371\/journal.ppat.1000928","article-title":"Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis","volume":"6","author":"Vartanian","year":"2010","journal-title":"PLoS Pathog"},{"key":"key20200713120710_b11-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1126\/science.1153201","article-title":"Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions","volume":"320","author":"Vartanian","year":"2008","journal-title":"Science"},{"key":"key20200713120710_b12-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/S1462399409001343","article-title":"Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: Implications for therapeutics","volume":"12","author":"Albin","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"key20200713120710_b13-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1182\/blood-2013-06-508861","article-title":"An animal model of adult T-cell leukemia: Humanized mice with HTLV-1-specific immunity","volume":"123","author":"Tezuka","year":"2014","journal-title":"Blood"},{"key":"key20200713120710_b14-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2009.08.011","article-title":"Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD\/SCID\/IL-2Rgammanull mice","volume":"394","author":"Nie","year":"2009","journal-title":"Virology"},{"key":"key20200713120710_b15-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","article-title":"The APOBEC protein family: United by structure, divergent in function","volume":"41","author":"Salter","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"key20200713120710_b16-etm-0-0-7375","first-page":"79","article-title":"HTLV-1 oncoprotein tax and cellular transcription factors","volume":"193","author":"Yoshida","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20200713120710_b17-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1128\/JVI.76.6.2703-2713.2002","article-title":"Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression","volume":"76","author":"Furuta","year":"2002","journal-title":"J Virol"},{"key":"key20200713120710_b18-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20032042","article-title":"Increased expression of human T lymphocyte virus type I (HTLV\u2013I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+CD25+ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-1-associated neurologic disease","volume":"199","author":"Yamano","year":"2004","journal-title":"J Exp Med"},{"key":"key20200713120710_b19-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"key20200713120710_b20-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1365-2249.2000.01136.x","article-title":"Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers","volume":"119","author":"Araki","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"key20200713120710_b21-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molmed.2015.02.007","article-title":"APOBEC3 genes: Retroviral restriction factors to cancer drivers","volume":"21","author":"Henderson","year":"2015","journal-title":"Trends Mol Med"},{"key":"key20200713120710_b22-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12977-014-0089-5","article-title":"HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity","volume":"11","author":"Wang","year":"2014","journal-title":"Retrovirology"},{"key":"key20200713120710_b23-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"39507","DOI":"10.1038\/srep39507","article-title":"Translational regulation of APOBEC3G mRNA by Vif requires its 5\u2032UTR and contributes to restoring HIV-1 infectivity","volume":"6","author":"Guerrero","year":"2016","journal-title":"Sci Rep"},{"key":"key20200713120710_b24-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1128\/JVI.02239-09","article-title":"APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo","volume":"84","author":"Fan","year":"2010","journal-title":"J Virol"},{"key":"key20200713120710_b25-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1128\/JVI.06570-11","article-title":"APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1","volume":"86","author":"Ooms","year":"2012","journal-title":"J Virol"},{"key":"key20200713120710_b26-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/14712598.2016.1233962","article-title":"Activating the innate immune response to counter chronic hepatitis B virus infection","volume":"16","author":"Lamb","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"key20200713120710_b27-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/eji.201646603","article-title":"Triggering of TLR-3, \u22124, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells","volume":"47","author":"Cardinaud","year":"2017","journal-title":"Eur J Immunol"},{"key":"key20200713120710_b28-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"key20200713120710_b29-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"683095","DOI":"10.1155\/2013\/683095","article-title":"The role of cytidine deaminases on innate immune responses against human viral infections","volume":"2013","author":"Vieira","year":"2013","journal-title":"Biomed Res Int"},{"key":"key20200713120710_b30-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.2910450206","article-title":"The 4th nation-wide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. The T- and B-cell malignancy study group","volume":"45","author":"Tajima","year":"1990","journal-title":"Int J Cancer"},{"key":"key20200713120710_b31-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1038\/sj.onc.1208974","article-title":"Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation","volume":"24","author":"Lairmore","year":"2005","journal-title":"Oncogene"},{"key":"key20200713120710_b32-etm-0-0-7375","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13578-017-0156-4","article-title":"APOBEC3B, a molecular driver of mutagenesis in human cancers","volume":"7","author":"Zou","year":"2017","journal-title":"Cell Biosci"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:34:36Z","timestamp":1594640076000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7375","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}